Tetsuya Eto
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Immunology top 1%
- T-cell and Retrovirus Studies
- Complement system in diseases
Papers in
- Hematology 246
- Hematopoietic Stem Cell Transplantation 229
- Acute Myeloid Leukemia Research 28
- Chronic Myeloid Leukemia Treatments 10
- Immunology 35
- T-cell and Retrovirus Studies 28
- Co-authors
- Takahiro Fukuda (126 shared papers)Yoshiko Atsuta (130 shared papers)Toshihiro Miyamoto (63 shared papers)Koichi Akashi (50 shared papers)Shuichi Taniguchi (34 shared papers)Koji Nagafuji (47 shared papers)Kazuteru Ohashi (44 shared papers)Takanori Teshima (38 shared papers)
- Journals
- Bone Marrow Transplantation (67 papers)Transplantation and Cellular Therapy (52 papers)International Journal of Hematology (29 papers)Blood (22 papers)British Journal of Haematology (22 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Tetsuya Eto
335 papers receiving 6.6k citations
Tetsuya Eto's Hit Papers
Peers
Comparison fields: 5 of 102
- Hematology 3k
- Immunology 1.5k
- Genetics 312
- Pathology and Forensic Medicine 516
- Oncology 514
Countries citing papers authored by Tetsuya Eto
This map shows the geographic impact of Tetsuya Eto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Eto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Eto more than expected).
Fields of papers citing papers by Tetsuya Eto
This network shows the impact of papers produced by Tetsuya Eto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Eto. The network helps show where Tetsuya Eto may publish in the future.
Co-authors
The 25 scholars most cited alongside Tetsuya Eto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 361 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 333 | |
| 2 | 2011 | 247 | |
| 3 | 2015 | 243 | |
| 4 | 2010 | 236 | |
| 5 | 2012 | 172 | |
| 6 | 2012 | 148 | |
| 7 | 2014 | 137 | |
| 8 | 2015 | 135 | |
| 9 | Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 Hit paper breakdown → | 2024 | 121 |
| 10 | 2012 | 102 | |
| 11 | 1994 | 91 | |
| 12 | 2014 | 87 | |
| 13 | 2017 | 85 | |
| 14 | 2009 | 80 | |
| 15 | 2004 | 79 | |
| 16 | 1997 | 78 | |
| 17 | 2019 | 78 | |
| 18 | 1997 | 76 | |
| 19 | 2013 | 73 | |
| 20 | 1996 | 71 |
About Tetsuya Eto
Tetsuya Eto is a scholar working on Hematology, Immunology, Pathology and Forensic Medicine, Oncology and Epidemiology, having authored 361 papers that have together received 6.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (229 papers), Acute Myeloid Leukemia Research (28 papers), T-cell and Retrovirus Studies (28 papers), Lymphoma Diagnosis and Treatment (19 papers), Cytomegalovirus and herpesvirus research (17 papers), Acute Lymphoblastic Leukemia research (15 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Neuropeptides and Animal Physiology (9 papers). The work is most often cited by research in Hematology (3k citations), Immunology (1.5k citations), Genetics (312 citations), Pathology and Forensic Medicine (516 citations) and Oncology (514 citations). Tetsuya Eto has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takahiro Fukuda, Yoshiko Atsuta, Toshihiro Miyamoto, Koichi Akashi, Shuichi Taniguchi, Koji Nagafuji, Kazuteru Ohashi, Takanori Teshima, Naoyuki Uchida and Tatsuo Ichinohe. Their work appears in journals such as Bone Marrow Transplantation, Transplantation and Cellular Therapy, International Journal of Hematology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.